BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32483733)

  • 1. Relapsed Osteosarcoma Trial Concepts to Match the Complexity of the Disease.
    Reed DR; Hingorani P; Anderson PM
    Adv Exp Med Biol; 2020; 1257():85-94. PubMed ID: 32483733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiopharmaceuticals for Treatment of Osteosarcoma.
    Anderson PM
    Adv Exp Med Biol; 2020; 1257():45-53. PubMed ID: 32483729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
    Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P
    Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Standards and Options for the use of radiation therapy in the management of patients with osteosarcoma. Update 2004].
    Claude L; Rousmans S; Carrie C; Breteau N; Dijoud F; Gentet JC; Giammarile F; Jouve JL; Kind M; Marec-Bérard P; Mascard E; Bataillard A; Philip T; ; ; ; ; ;
    Cancer Radiother; 2005 Mar; 9(2):104-21. PubMed ID: 15880886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
    Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
    J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of adjuvant chemotherapy in the management of sarcomas in children.
    Donaldson SS
    Cancer; 1985 May; 55(9 Suppl):2184-97. PubMed ID: 3884137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteosarcoma: review of the past, impact on the future. The American experience.
    Jaffe N
    Cancer Treat Res; 2009; 152():239-62. PubMed ID: 20213394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma.
    Kleinerman ES; Gano JB; Johnston DA; Benjamin RS; Jaffe N
    Am J Clin Oncol; 1995 Apr; 18(2):93-9. PubMed ID: 7900714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients.
    Bacci G; Longhi A; Bertoni F; Briccoli A; Versari M; Pignotti E; Picci P
    Acta Orthop; 2006 Dec; 77(6):938-43. PubMed ID: 17260205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modern views on the treatment of osteogenic sarcoma].
    Górecki A; Dulowski W; Małdyk P; Adamkiewicz T
    Wiad Lek; 1982 Jun; 35(6):426-32. PubMed ID: 6957070
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiation in bone sarcomas: a re-evaluation in the era of intensive systemic chemotherapy.
    Tefft M; Chabora BM; Rosen G
    Cancer; 1977 Feb; 39(2 Suppl):806-16. PubMed ID: 402197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteosarcoma: Conventional treatment vs. gene therapy.
    Tan ML; Choong PF; Dass CR
    Cancer Biol Ther; 2009 Jan; 8(2):106-17. PubMed ID: 19098456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term adjuvant interferon treatment of human osteosarcoma. A pilot study.
    Strander H; Bauer HC; Brosjö O; Fernberg JO; Kreicbergs A; Nilsonne U; Silfverswärd C; Signomklao T; Söderlund V
    Acta Oncol; 1995; 34(6):877-80. PubMed ID: 7576758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Mercuri M; Bertoni F; Picci P; Manfrini M; Gasbarrini A; Forni C; Cesari M; Campanacci M
    Acta Orthop Scand; 1998 Jun; 69(3):230-6. PubMed ID: 9703394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteosarcoma. Clinical features and evolving surgical and chemotherapeutic strategies.
    Meyer WH; Malawer MM
    Pediatr Clin North Am; 1991 Apr; 38(2):317-48. PubMed ID: 2006080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment of high grade osteosarcoma of the extremity: review.
    Bacci G; Lari S
    J Chemother; 2001 Jun; 13(3):235-43. PubMed ID: 11450880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Treatment Considerations for Osteosarcoma Metastatic at Presentation.
    Tsukamoto S; Errani C; Angelini A; Mavrogenis AF
    Orthopedics; 2020 Sep; 43(5):e345-e358. PubMed ID: 32745218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteosarcoma -- surgery, radiotherapy and chemotherapy.
    Flatman GE
    Radiography; 1978 Feb; 44(518):35-40. PubMed ID: 272705
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.
    Hundsdoerfer P; Albrecht M; Rühl U; Fengler R; Kulozik AE; Henze G
    Eur J Cancer; 2009 Sep; 45(14):2447-51. PubMed ID: 19596190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy for osteosarcoma: preoperative and postoperative treatment.
    Eilber FR; Grant T; Morton DL
    Cancer Treat Rep; 1978 Feb; 62(2):213-6. PubMed ID: 346209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.